Evaluation of the CloSys Closure System as an Adjunct to Standard Compression

Stopped early · Not applicable

Conditions studied: Sealing the Arteriotomy

In brief

The purpose of this study is to evaluate the safety and efficacy of the CloSys Hemostatic Device designed to stop bleeding after an interventional procedure.

Key facts

Study ID

NCT00963690

Run by

CloSys Corporation

People needed

30

Starts

2009-08-01

Expected to finish

2013-05-30

Last updated by the study team

2017-01-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Cardiovascular Institute of the South — Lafayette, Louisiana, United States
• Rex Healthcare - Rex Heart and Vascular Research — Raleigh, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.